Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system

Código QR

Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system

Maria João Gomes,1 José das Neves,1,2 Bruno Sarmento1,2 1Instituto de Engenharia Biomédica (INEB), Porto, Portugal; 2Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Sa&ua...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gomes MJ, das Neves J, Sarmento B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b52475b44fcb40cdb2ab4930af5b2d8f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
por: Ameya R. Kirtane, et al.
Publicado: (2018)

Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain
por: Patel BK, et al.
Publicado: (2018)

Central nervous system toxicity of metallic nanoparticles
por: Feng XL, et al.
Publicado: (2015)

Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review
por: Li J, et al.
Publicado: (2020)

Patient Reported Central Nervous System Adverse Events of Efavirenz-Based Antiretroviral Therapy in People Living with HIV in Northwest Ethiopia
por: Muche EA, et al.
Publicado: (2020)

Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy
por: Cover NF, et al.
Publicado: (2012)

Management of HIV/AIDS in older patients–drug/drug interactions and adherence to antiretroviral therapy
por: Burgess MJ, et al.
Publicado: (2015)

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
por: James J. Hobson, et al.
Publicado: (2019)

Self-Microemulsifying Drug Delivery System for Improved Oral Delivery and Hypnotic Efficacy of Ferulic Acid
por: Liu CS, et al.
Publicado: (2020)

Progress in antiretroviral drug delivery using nanotechnology
por: Rama Mallipeddi, et al.
Publicado: (2010)

Self-buffering capacity of a human sulfatase for central nervous system delivery
por: Yi Wen, et al.
Publicado: (2021)

Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells
por: Arvind Kumar, et al.
Publicado: (2009)

PPARα Modulation-Based Therapy in Central Nervous System Diseases
por: Deokho Lee, et al.
Publicado: (2021)

Efferocytosis in the Central Nervous System
por: Jiayi Zhao, et al.
Publicado: (2021)

Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy
por: Sun JG, et al.
Publicado: (2019)

Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis
por: Marcianes P, et al.
Publicado: (2017)

The Influence of Size and Chemical Composition of Silver and Gold Nanoparticles on in vivo Toxicity with Potential Applications to Central Nervous System Diseases
por: Báez DF, et al.
Publicado: (2021)

Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review
por: Nkune Williams Nkune, et al.
Publicado: (2021)

Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity
por: Tokajuk G, et al.
Publicado: (2017)

Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy
por: Siro Luvisetto
Publicado: (2021)

Nanoparticle Drug Delivery Systems for α-Mangostin
por: Wathoni N, et al.
Publicado: (2020)

Role of the Extracellular Traps in Central Nervous System
por: Xinyan Wu, et al.
Publicado: (2021)

Effects of bromadiolone poisoning on the central nervous system
por: Wang M, et al.
Publicado: (2017)

Solid Lipid Nanoparticles: An Approach to Improve Oral Drug Delivery
por: Nestor Mendoza-Muñoz, et al.
Publicado: (2021)

Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders
por: Yavarpour-Bali H, et al.
Publicado: (2019)

Curcumin-coordinated nanoparticles with improved stability for reactive oxygen species-responsive drug delivery in lung cancer therapy
por: Luo CQ, et al.
Publicado: (2017)

&nbsp;&alpha;-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies
por: Shityakov S, et al.
Publicado: (2012)

Targeted Delivery of Erythropoietin Hybridized with Magnetic Nanocarriers for the Treatment of Central Nervous System Injury: A Literature Review
por: Hwang CH
Publicado: (2020)

Biologics: the role of delivery systems in improved therapy
por: &Scaron;kalko-Basnet N
Publicado: (2014)

Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy
por: Lee PC, et al.
Publicado: (2019)

Doxycycline promotes proteasome fitness in the central nervous system
por: Edmund Charles Jenkins, et al.
Publicado: (2021)

Mechanisms of magnetic stimulation of central nervous system neurons.
por: Tamar Pashut, et al.
Publicado: (2011)

Potential toxicity of dental nanomaterials to the central nervous system
por: Solla DF, et al.
Publicado: (2015)

Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy
por: Anna Florczak, et al.
Publicado: (2021)

ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function.
por: Huijing Xia, et al.
Publicado: (2011)

Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
por: Tang L, et al.
Publicado: (2021)

CENTRAL HYPOTHROIDISM DUE TO ACUTE LYMPHOBLASTIC LEUKEMIA WITH CENTRAL NERVOUS SYSTEM INFILTRATION
por: Dilek Kaçar, et al.
Publicado: (2021)

Human Immunodeficiency Virus Type-1 (HIV-1) Transcriptional Regulation, Latency and Therapy in the Central Nervous System
por: Joseph Hokello, et al.
Publicado: (2021)

Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
por: Rúben G. R. Pinheiro, et al.
Publicado: (2021)

Potential drug–drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria
por: Oshikoya KA, et al.
Publicado: (2014)